The latest biotech news

News and Trends 27 Apr 2016

Interviewing the CEO who uses Probiotics as Needle-free Vaccines

This is my first interview from BioTrinity 2016 in London. I met with Tom Johnston, CEO of Mucosis, to learn more about the needle-free vaccine platform he is developing. Mucosis is a biotechnology company based in Gröningen, Netherlands (a city we covered here for its medtech innovation). It was founded in 2007 and has raised over €20M so […]

April 27, 2016 - 1 minutemin - By Philip Hemme

News and Trends 26 Apr 2016

Illumina is Suing over NGS Prenatal Screening… Again

Genoma is being sued by Illumina over four patents covering technology for prenatal testing, that uses NGS to diagnose fetal defects. After suing Oxford Nanopore over porin technology, Illumina is back to another contentious field – their patents for a type of non-invasive prenatal testing (NIPT). Illumina has filed a patent infringement suit in the Federal […]

April 26, 2016 - 2 minutesmins - By Denise Neves Gameiro

value biotech actelion finance europe 2016 infographic pyramid market cap

News and Trends 26 Apr 2016

Infographic: Which are the most Valuable Biotechs in Europe?

It’s been an interesting year for Biotech, as we repeatedly stress. But there are some biotechs which have been less robust against these tumultuous times, whilst others which have ‘made it big’. As we’ve also started examining individual European cities for an overview of their Biotech community (such as London – and Paris) it is […]

April 26, 2016 - 2 minutesmins - By Dani Bancroft

bioviva ageing gene therapy telomerase parrish

News and Trends 25 Apr 2016

Anti-ageing DIY Gene Therapy may have worked – to an extent…

The weird tale of BioViva‘s CEO receiving non-approved gene therapy to fight ageing has developed further – now with ‘successful results’, which have been verified by two EU research NGOs. There may be something to it after all? Stopping ageing has always been a dream of mankind – and one that is slowly beginning to […]

April 25, 2016 - 3 minutesmins - By Denise Neves Gameiro

astrazeneca centre genomics research hli wellcome fimm

News and Trends 25 Apr 2016

AstraZeneca partners up with Genomics Elite for new Biobank

AstraZeneca has announced it will create a new Centre for Genomics Research in Cambridge (UK) – joining the Wellcome Sanger, a Craig Venter Biotech and a Finnish specialist Institute to do so. AstraZeneca is betting on genomics to transform drug discovery and support its R&D pipeline. The idea is to create a ‘biobank‘ with genome analysis, integrated with data from […]

April 25, 2016 - 3 minutesmins - By Denise Neves Gameiro

kiweno bianca gfrei lecture food intolerance diagnostic

News and Trends 25 Apr 2016

The DIY Allergy Blood Test inspiring Austria’s startup Scene

I got to hear the interesting story and business model of kiweno, a digital health startup and rising star in Austria. What’s the product, where is the demand and were there challenges with perceptions after the Theranos scandal? Berlin has a lot of exciting events to feed the thriving startup scene here. And really at […]

April 25, 2016 - 6 minutesmins - By Denise Neves Gameiro

TC biopharm immunicell melanoma kidney cancer

News and Trends 25 Apr 2016

Scottish Biopharma begins Cell Therapy trials for Late-Stage Cancer

TC BioPharm has began recruitment to a phase II/III trial with its lead candidate (ImmuniCell), a T-cell therapy now targeting skin, lung and kidney cancer. Based in Scotland, TC BioPharm is developing cell-based therapies for cancer and severe viral infection. These therapies are based on γδ T-cells, which can recognise and target specific structures on the cell surface […]

April 25, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 24 Apr 2016

What happened this week? Top 10 London Biotechs, CRISPR, AACR

1. Here are 10 Awesome London based Biotechs 2. ITW: This Biotech Startup wants to fix Youth Blindness with a Gene Therapy 3. These EU Biotechs presented groundbreaking results at World Biggest Cancer Meeting 4. New CRISPR Tool can cut RNA too: Gene Editing just got even Easier! 5. Who are France’s Young Innovators in […]

April 24, 2016 - 1 minutemin - By Philip Hemme

Katharine dowson bioart science gallery hiv brain malformation glass

News and Trends 23 Apr 2016

BioArt : Katharine Dowson’s Brain Boxes, Crystal Chromosomes & HIV Vaccine Work

Represented by the GV Art Gallery in London, Katharine Dowson is a glass sculptor who is well established in the BioArt community as an Anatomical and medicine specialist. Katharine studied at the Royal College of Art and Camberwell in London, with a focus spanning to include the anatomical form (particularly the Nervous system) to infectious diseases and developmental research into a […]

April 23, 2016 - 4 minutesmins - By Dani Bancroft

cannabis cannabidiol gw pharmaceuticals tuberous sclerosis complex epilepsy biotech fda orphan drug trials

News and Trends 22 Apr 2016

UK Cannabis Biotech gets another Orphan Drug Designation by the FDA

Cambridge based GW Pharmaceuticals has now been granted Orphan Drug Designation from FDA for Cannabidiol drug to treat a 3rd rare genetic form of epilepsy. GW Pharmaceuticals has been granted Orphan Drug Designation for cannabidiol (CBD) for the treatment of Tuberous Sclerosis Complex (TSC). Epidiolex is a liquid formulation of pure plant-derived CBD, which is in development for […]

April 22, 2016 - 2 minutesmins - By Dani Bancroft

News and Trends 22 Apr 2016

Biotech of the Week: Covagen, binding proteins to antibodies for Immunotherapy

We say our goodbyes to Belgium this week and head one more time to Switzerland. In Zürich, where you can find almost any kind of cheese, delicious chocolate and a beautiful view of the Swiss Alps near the city lake, is also where Covagen, our Biotech of the Week is located. City: Zürich (Switzerland) Founded: 2007 Employees: 23 (as of […]

April 22, 2016 - 2 minutesmins - By Joachim Eeckhout

saphetor ngs lausanne university hospital endocrine

News and Trends 22 Apr 2016

Swiss Biotech to Investigate rare Endocrine Disorders with NGS

Saphetor is developing genome-scale analysis of next generation sequencing (NGS) results – and will now ‘play’ with real data of Endocrine patients at the Lausanne University Hospital. Based in Lausanne’s EPFL Innovation Park (Switzerland), Saphetor was founded only in 2014 and completed a seed financing round this February, raising around €1M (1.2M CHF). This startup develops proprietary […]

April 22, 2016 - 2 minutesmins - By Denise Neves Gameiro

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

Interviewing the CEO who uses Probiotics as Needle-free Vaccines

Illumina is Suing over NGS Prenatal Screening… Again

Infographic: Which are the most Valuable Biotechs in Europe?

Anti-ageing DIY Gene Therapy may have worked – to an extent…

AstraZeneca partners up with Genomics Elite for new Biobank

The DIY Allergy Blood Test inspiring Austria’s startup Scene

Scottish Biopharma begins Cell Therapy trials for Late-Stage Cancer

What happened this week? Top 10 London Biotechs, CRISPR, AACR

BioArt : Katharine Dowson’s Brain Boxes, Crystal Chromosomes & HIV Vaccine Work

UK Cannabis Biotech gets another Orphan Drug Designation by the FDA

Biotech of the Week: Covagen, binding proteins to antibodies for Immunotherapy

Swiss Biotech to Investigate rare Endocrine Disorders with NGS

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!